Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma

Journal of Dermatological Science

Volumn 53, Issue 2, 2009, Pages 140-145

  Sato, Kazuomi ^a   Toriyama, Masaru ^a  

^a SHIZUOKA UNIVERSITY   (Japan)

Author keywords

Melanogenesis; Microphthalmia associated transcription factor (Mitf); Pyrroloquinoline quinone (PQQ); Tyrosinase; Tyrosinase related protein (TRP)

Indexed keywords

ALPHA INTERMEDIN; ISOBUTYLMETHYLXANTHINE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; PYRROLOQUINOLINEQUINONE; TYROSINASE RELATED PROTEIN 1; TYROSINASE RELATED PROTEIN 2;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEPIGMENTATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

1-METHYL-3-ISOBUTYLXANTHINE; ALPHA-MSH; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; INTRAMOLECULAR OXIDOREDUCTASES; MELANINS; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PIGMENTATION; PQQ COFACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 57649178818     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.08.017     Document Type: Article

References (40)

1. Salisbury S.A., Forrest H.S., Cruse W.B., and Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 280 (1979) 843-844
2. Stites T.E., Mitchell A.E., and Rucker R.B. Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr 130 (2000) 719-727
3. McIntire W.S. Newly discovered redox cofactors: possible nutritional, medical, and pharmacological relevance to higher animals. Annu Rev Nutr 18 (1998) 145-177
4. Goodwin P.M., and Anthony C. The biochemistry, physiology and genetics of PQQ and PQQ-containing enzymes. Adv Microb Physiol 40 (1998) 1-80
5. Kumazawa T., Seno H., Urakami T., Matsumoto T., and Suzuki O. Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim Biophys Acta 1156 (1992) 62-66
6. Mitchell A.E., Jones A.D., Mercer R.S., and Rucker R.B. Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem 269 (1999) 317-325
7. Kumazawa T., Sato K., Seno H., Ishii A., and Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem J 307 (1995) 331-333
8. Naito Y., Kumazawa T., Kino I., and Suzuki O. Effects of pyrroloquinoline quinine (PQQ) and PQQ-oxazole on DNA synthesis of cultured human fibroblasts. Life Sci 52 (1993) 1909-1915
9. Stites T., Storms D., Bauerly K., Mah J., Harris C., Fascetti A., et al. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 136 (2006) 390-396
10. Misra H.S., Khairnar N.P., Barik A., Indira Priyadarsini K., and Mohan H. Apte SKPyrroloquinoline-quinone: a reactive oxygen species scavenger in bacteria. FEBS Lett 578 (2004) 26-30
11. He K., Nukada H., Urakami T., and Murphy M.P. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol 65 (2003) 67-74
12. Hara H., Hiramatsu H., and Adachi T. Pyrroloquinoline quinone is a potent europrotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res 32 (2007) 489-495
13. Hearing V.J., and Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 5 (1991) 2902-2909
14. Jackson I.J., Chambers D.M., Tsukamoto K., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J 11 (1992) 527-535
15. Kameyama K., Takemura T., Hamada Y., Sakai C., Kondoh S., Nishiyama S., et al. Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. J Invest Dermatol 100 (1993) 126-131
16. Tsukamoto K., Jackson I.J., Urabe K., Montague P.M., and Hearing V.J. A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11 (1992) 519-526
17. Aroca P., Solano F., Salinas C., Garcia-Borron J.C., and Lozano J.A. Regulation of the final phase of mammalian melanogenesis. The role of dopachrome tautomerase and the ratio between 5,6-dihydroxyindole-2-carboxylic acid and 5,6-dihydroxyindole. Eur J Biochem 208 (1992) 155-163
18. Korner A., and Pawelek J. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. Science 217 (1982) 1163-1165
19. Steingrimsson E., Copeland N.G., and Jenkins N.A. Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38 (2004) 365-411
20. Busca R., and Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 13 (2000) 60-69
21. Tachibana M. MITF: a stream flowing for pigment cells. Pigment Cell Res 13 (2000) 230-240
22. Romero-Graillet C., Aberdam E., Biagoli N., Massabni W., Ortonne J.P., and Ballotti R. Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 271 (1996) 28052-28056
23. Park H.Y., Perez J.M., Laursen R., Hara M., and Gilchrest B.A. Protein kinase C-β activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem 274 (1999) 16470-16478
24. Saito N., Kikkawa U., and Nishizuka Y. The family of protein kinase C and membrane lipid mediators. J Diabetes Complications 16 (2002) 4-8
25. Kosano H., Setogawa T., Kobayashi K., and Nishigori H. Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by α-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci 56 (1995) 1707-1713
26. Tsuboi T., Kondoh H., Hiratsuka J., and Mishima Y. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 11 (1998) 275-282
27. Korner A.M., and Pawelek J. Dopachrome conversion: a possible control point in melanin biosynthesis. J Invest Dermatol 75 (1980) 192-195
28. Pawelek J., Korner A., Bergstrom A., and Bologna J. New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 286 (1980) 617-619
29. Chakraborty A.K., Funasaka Y., Komoto M., and Ichihashi M. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res 11 (1998) 206-212
30. Laskin J.D., and Piccinini L.A. Tyrosinase isozyme heterogeneity in differentiating B16/C3 melanoma. J Biol Chem 261 (1986) 16626-16635
31. Funasaka Y., Chakraborty A.K., Komoto M., Ohashi A., and Ichihashi M. The depigmenting effect of α-tocopheryl ferulate on human melanoma cells. Br J Dermatol 141 (1999) 20-29
32. Ichihashi M., Funasaka Y., Ohashi A., Chacraborty A., Ahmed N.U., Ueda M., et al. The inhibitory effect of DL-α-tocopheryl ferulate in lecithin on melanogenesis. Anticancer Res 19 (1999) 3769-3774
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
34. Im S., Moro O., Peng F., Medrano E.E., Cornelius J., Babcock G., et al. Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes toultraviolet B radiation. Cancer Res 58 (1998) 47-54
35. Jimenez M., Tsukamoto K., and Hearing V.J. Tyrosinases from two different loci are expressed by normal and by transformed melanocytes. J Biol Chem 266 (1991) 1147-1156
36. Kim K.S., Kim J.A., Eom S.Y., Lee S.H., Min K.R., and Kim Y. Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression. Pigment Cell Res 19 (2006) 90-98
37. Brechler V., Pavoine C., Hanf R., Garbarz E., Fischmeister R., and Pecker F. Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein. J Biol Chem 267 (1992) 15496-15501
38. Tachibana M., Kobayashi Y., and Matsushima Y. Mouse models for four types of Waardenburg syndrome. Pigment Cell Res 16 (2003) 448-454
39. Tomita Y., Miyamura Y., Kono M., Nakamura R., and Matsunaga J. Molecular bases of congenital hypopigmentary disorders in humans and oculocutaneous albinism 1 in Japan. Pigment Cell Res 13 Suppl. 8 (2000) 130-134
40. Fisher D.E. Microphthalmia: a signal responsive transcriptional regulator in development. Pigment Cell Res 13 Suppl. 8 (2000) 145-149